Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 YMC Acquires ChromaCon Biz | Contract Pharma
Breaking News

YMC Acquires ChromaCon Biz

Expands footprint in multi-column continuous purification technologies

YMC Co., Ltd., a supplier of separation resins, services and systems for the pharmaceutical market, has acquired ChromaCon AG of Zurich, Switzerland.

ChromaCon has a portfolio of continuous chromatography technologies and markets laboratory scale separation/purification systems using these technologies. ChromaCon technology offers twin-column purification to increase productivity in both large and small molecule manufacturing.

YMC and ChromaCon have maintained a strategic business alliance with YMC being an exclusive distributor of ChromaCon’s lab-scale systems in Japan and India. ChromaCon had also licensed technologies to YMC Process Technologies for GMP production scale equipment. YMC completed its acquisition of YPT from LEWA-Nikkiso America December 2018. YPT develops and manufactures scale-up separation systems for the pharmaceutical manufacturing industry.

With ChromaCon, YMC has now a fully integrated organization for the development and commercialization of continuous separation/purification systems for biopharmaceutical and pharmaceutical industry from lab to production scale (GMP) manufacturing.
YMC Group is furthering its investment with the expansion of R&D of the continuous separation/purification platform in its Kyoto, Japan, site where YMC is building a new facility, scheduled to start operations in October 2019.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters